Design, synthesis and in vitro characterization of Glucagon-Like Peptide-1 derivatives for pancreatic beta cell imaging by SPECT

被引:18
作者
Azad, Babak Behnam [1 ]
Rota, Vanessa A. [2 ]
Breadner, Daniel [1 ]
Dhanvantari, Savita [2 ,3 ,4 ,7 ]
Luyt, Leonard G. [1 ,5 ,6 ]
机构
[1] Univ Western Ontario, Dept Chem, London, ON N6A 5B7, Canada
[2] Univ Western Ontario, Dept Med Biophys, London, ON N6A 5B7, Canada
[3] Univ Western Ontario, Dept Med, London, ON N6A 5B7, Canada
[4] Univ Western Ontario, Dept Pathol, London, ON N6A 5B7, Canada
[5] Univ Western Ontario, Dept Med Imaging, London, ON N6A 5B7, Canada
[6] London Reg Canc Program, Dept Oncol, London, ON N6A 4L6, Canada
[7] Lawson Hlth Res Inst, Imaging Programs, London, ON N6A 4V2, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Molecular imaging; Glucagon-Like Peptide-1; Indium-111; Metal conjugates; Beta cells; Pancreatic islets; SPECT; IV-RESISTANT ANALOGS; GLP-1; RECEPTOR; PLASMA STABILITY; DOTA; EXENDIN-4; BIOLOGY; VIVO; GLUCAGON-LIKE-PEPTIDE-1; IDENTIFICATION; LIRAGLUTIDE;
D O I
10.1016/j.bmc.2009.12.032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Novel Glucagon-Like Peptide-1 (GLP-1) derivatives containing the metal chelator DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) and naturally occurring Indium (In-113/115) were prepared using solid-phase Fmoc methods. All synthesized peptides contained D-Ala-8, a modification known to improve resistance towards degradation by dipeptidyl peptidase-IV. The effect of increased distance between DOTA and the peptide chain was investigated using an (aminoethyl) ethoxy acetyl linker, in order to reduce steric effects imposed by DOTA. Placement of linker and DOTA moieties were also varied within the GLP-1 sequence to test for optimal metal-complex location. The binding affinity of the peptide derivatives was determined in vitro with Chinese hamster ovary cells stably transfected with a human GLP-1 receptor (CHO/GLP-1R) cell line and was shown to be in the nM range. Gamma camera imaging of an insulinoma cell line was carried out using In-111-labeled peptides. Our results suggest that the prepared GLP-1 derivatives are suitable imaging probes for studying pancreatic islet function in vivo. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1265 / 1272
页数:8
相关论文
共 43 条
[1]
ADELHORST K, 1994, J BIOL CHEM, V269, P6275
[2]
A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors [J].
Al-Sabah, S ;
Donnelly, D .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (02) :339-346
[3]
Direct synthesis of [DOTA-DPhe1]-octreotide and [DOTA-DPhe1,Tyr3]-octreotide (SMT487):: Two conjugates for systemic delivery of radiotherapeutical nuclides to somatostatin receptor positive tumors in man [J].
Albert, R ;
Smith-Jones, P ;
Stolz, B ;
Simeon, C ;
Knecht, H ;
Bruns, C ;
Pless, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (10) :1207-1210
[4]
ALDRICH JV, 2006, Patent No. 7038078
[5]
Medium-dependence of the secondary structure of exendin-4 and glucagon-like-peptide-1 [J].
Andersen, NH ;
Brodsky, Y ;
Neidigh, JW ;
Prickett, KS .
BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (01) :79-85
[6]
Biology of incretins: GLP-1 and GIP [J].
Baggio, Laurie L. ;
Drucker, Daniel J. .
GASTROENTEROLOGY, 2007, 132 (06) :2131-2157
[7]
GLP-1 receptor signaling:: effects on pancreatic β-cell proliferation and survival [J].
Buteau, J. .
DIABETES & METABOLISM, 2008, 34 :S73-S77
[8]
Glucagon-Like Peptide-1 Receptor Imaging for Localization of Insulinomas [J].
Christ, Emanuel ;
Wild, Damian ;
Forrer, Flavio ;
Braendle, Michael ;
Sahli, Rahel ;
Clerici, Thomas ;
Gloor, Beat ;
Martius, Ferdinand ;
Maecke, Helmut ;
Reubi, Jean Claude .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (11) :4398-4405
[9]
The synthesis and chelation chemistry of DOTA-peptide conjugates [J].
De Leon-Rodriguez, Luis M. ;
Kovacs, Zoltan .
BIOCONJUGATE CHEMISTRY, 2008, 19 (02) :391-402
[10]
Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity [J].
Deacon, CF ;
Knudsen, LB ;
Madsen, K ;
Wiberg, FC ;
Jacobsen, O ;
Holst, JJ .
DIABETOLOGIA, 1998, 41 (03) :271-278